Results 261 to 270 of about 7,765,049 (335)
Multistage feature selection and stacked generalization model for cancer detection. [PDF]
Das S, Chaudhuri AK, Das S, Ghosh P.
europepmc +1 more source
A HADOOP-Based Framework for Parallel and Distributed Feature Selection [PDF]
Joanna Hodge, Tom Jackson, Jim Austin
openalex
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Multilabel feature selection using graph neural networks and differential evolution optimization. [PDF]
Pan N.
europepmc +1 more source
A Wrapper-Based Feature Selection for Analysis of Large Data Sets
Jinsong Leng +2 more
openalex +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Interpretable Biomechanical Feature Selection for VR Exercise Assessment Using SHAP and LDA. [PDF]
Czajkowska U +3 more
europepmc +1 more source
Checkpoint blockade and the stem‐like T cell trade‐off
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley +1 more source
HFSOF: A Hierarchical Feature Selection and Optimization Framework for Ultrasound-Based Diagnosis of Endometrial Lesions. [PDF]
Liu Y, Zhang Z, Chai T, Zhao H.
europepmc +1 more source
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source

